Splanchnic vein thrombosis in necrotizing pancreatitis: a post-hoc analysis of a nationwide prospective cohort

Noor J. Sissingh,Hester C. Timmerhuis,Jesse V. Groen,Mike J.P. de Jong,Marc G. Besselink,Bas Boekestijn,Thomas L. Bollen,Bert A. Bonsing,Stefan A.W. Bouwense,Wouter L. Hazen,Frederikus A. Klok,Hjalmar C. van Santvoort,Casper H.J. van Eijck,Robert C. Verdonk,J. Sven D. Mieog,Jeanin E. van Hooft,Dutch Pancreatitis Study Group
DOI: https://doi.org/10.1016/j.hpb.2024.01.011
IF: 3.842
2024-01-01
HPB
Abstract:BACKGROUND: Treatment guidelines for splanchnic vein thrombosis in necrotizing pancreatitis are lacking due to insufficient data on the full clinical spectrum.METHODS: We performed a post-hoc analysis of a nationwide prospective necrotizing pancreatitis cohort. Multivariable analyses were used to identify risk factors and compare the clinical course of patients with and without SVT.RESULTS: SVT was detected in 97 of the 432 included patients (22%) (median onset: 4 days). Risk factors were left, central, or subtotal necrosis (OR 28.52; 95% CI 20.11-40.45), right or diffuse necrosis (OR 5.76; 95% CI 3.89-8.51), and younger age (OR 0.94; 95% CI 0.90-0.97). Patients with SVT had higher rates of bleeding (n = 10,11%) and bowel ischemia (n = 4,4%) compared to patients without SVT (n = 14,4% and n = 2,0.6%; OR 3.24; 95% CI 1.27-8.23 and OR 7.29; 95% CI 1.31-40.4, respectively), and were independently associated with ICU admission (adjusted OR 2.53; 95% CI 1.37-4.68). Spontaneous recanalization occurred in 62% of patients (n = 40/71). Radiological and clinical outcomes did not differ between patients treated with and without anticoagulants.DISCUSSION: SVT is a common and early complication of necrotizing pancreatitis, associated with parenchymal necrosis and younger age. SVT is associated with increased complications and a worse clinical course, whereas anticoagulant use does not appear to affect outcomes.
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?